Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
metabolic syndrome
Research
Could this common heart drug prevent obesity?
The heart disease drug digoxin tamped down the inflammatory molecule IL-17A in mouse models of obesity, promoting weight loss, researchers reported.
Arlene Weintraub
Apr 16, 2021 8:10am
Retrophin buys up Orphan Technologies for rare disease drug
Oct 23, 2020 8:18am
Skyhawk Therapeutics boosts Merck collab pact with added targets
May 12, 2020 8:50am
Could gene therapy be the solution to obesity and diabetes?
Aug 29, 2019 1:00pm
Chemical shift reverses prediabetes in mouse trial
Jul 4, 2019 2:00pm
Canaan-backed Comet uncloaks with $28.5M and De Graaf as CEO
Jun 19, 2019 7:00am
